Hexiris Microinvasive Scleral Trephine (MIST) clinical trials

Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma

This study is testing a new device called MIST for people over 40 with a common type of glaucoma (POAG). It aims to lower eye pressure when eye drops aren't enough. Doctors will check how well it works and if it's safe over 12 months.